Irreversible inhibition, enzyme catalysis

Elucidating Mechanisms for the Inhibition of Enzyme Catalysis An inhibitor interacts with an enzyme in a manner that decreases the enzyme s catalytic efficiency. Examples of inhibitors include some drugs and poisons. Irreversible inhibitors covalently bind to the enzyme s active site, producing a permanent loss in catalytic efficiency even when the inhibitor s concentration is decreased. Reversible inhibitors form noncovalent complexes with the enzyme, thereby causing a temporary de-... 

We have already dealt with the subject of irreversible inhibitors under enzyme titration and location of the active site (Section 11.4.3.2). The phenomenon of reversible inhibition involves simple complexation of the inhibitor with the enzyme at a site which modifies the reactivity of the enzyme catalysis. 

This article describes various approaches to inhibition of enzyme catalysis. Reversible inhibition includes competitive, uncompetitive, mixed inhibition, noncompetitive inhibition, transition state, and slow tight-binding inhibition. Irreversible inhibition approaches include affinity labeling and mechanism-based enzyme inhibition. The kinetics of the various inhibition approaches are summarized, and examples of each type of Inhibition are presented. 

Irreversible Inhibition Studies If an enzyme is inactivated by a reagent that reacts with a specific amino acid residue, then one (or more) of the reagent-specific amino acid residues is involved in catalysis by that enzyme. 

Ret er.stble inhibition, in contrast with irreversible inhibition, is acterized by a rapid dissociation of the enzyme-inhibitor complex. In the type of reversible inhibition called competitive inhibition, an enzyme can bind substrate (forming an ES complex) or inhibitor 1) but not both (ESI). The competitive inhibitor often resembles the substrate and binds to the active site of the enzyme (Figure 8.15). The substrate is thereby prevented from binding to the same active site. A competitive inhibitor dimmishes the rate oj catalysis by reducing the pro-por/ion of enzyme molecules bound to a substrate. At any given inhibitor concentration, competitive inhibition can be relieved by increasing... 

Suicide inhibitors, or mechanism-based inhibitors are modified substrates that provide the most specific means to modify an enzyme active site. The inhibitor binds to the enzyme as a substrate and is initially processed by the normal catalytic mechanism. The mechanism of catalysis then generates a chemically reactive intermediate that inactivates the enzyme through covalent modification. The fact that the enzyme participates in its own irreversible inhibition strongly suggests that the covalently modified group on the enzyme is catalytically vital. One example of such an inhibitor is N,N-dimethylpropargylamine. A flavin prosthetic group of monoamine oxidase... 

Mechanism-based CYP inhibition or irreversible inhibition, involves permanent inactivation of CYP enzymes during catalysis, where reactive intermediate(s) are formed, leading to apoprotein or heme-ion center modification. Typical characteristics of mechanism-based enzyme inhibition include time-dependent loss of enzyme activity, a rate of inactivation generally following saturation kinetics, enzyme activity that cannot be recovered after... 

The activity of an enzyme can be modulated reversibly or irreversibly by inhibitors and inactivators. The kinetics of inhibition and/or inactivation provide valuable insights into the nature of essential and/or catalytic residues as well as the mechanism of enzyme catalysis. 

Certain constituents when added to the reaction mixture, slow down the rate of reaction. This phenomena is called inhibition and constituent called inhibitor. Such an effect is similar to the negative catalysis. But the constituent usually undergoes chemical change, inhibition is the preferred term. Inhibition may occur in chain reactions, enzyme catalysed reactions, surface reactions or many reversible or irreversible reactions. A trace amount of an inhibitor may cause a marked decrease in the rate of reaction. The inhibitor sometimes combines with a catalyst and prevents it from catalyzing the reaction. 

Inhibition can be reversible when it simply complexes at the active site preventing further catalysis. The active enzyme under these conditions can be recovered by dialysis. Another form of inhibition is the irreversible type where the active enzyme cannot be recovered by dialysis. A variant of this type of inhibition is suicide inhibition a substrate of the enzyme reacts at the active site to yield an irreversible inhibitor which then reacts directly with groups at the active site [18]. A technique, in situ click chemistry , is related to that of suicide inhibition and involves click chemistry components which complex at the active site of an enzyme and combine to form femtomolar inhibitors. The technique can be used to synthesise inhibitors or by selection from a library of click chemistry components to search structure space of the inhibitor for the drug target [ 19]. 

Both AChE and BChE are of the serine hydrolase class, which includes proteases such as trypsin (see PROTEASE inhibitors). Characteristically, such enzymes can be inhibited through covalent linkage of constituent parts of irreversible anticholinesterases such as dyflos (DFP, diisopropylfluorophosphonate). The active site of the enzyme contains a catalytic triad with a glutamate residue, a serine residue and a histidine imidazole ring. The mechanism of the catalysis of break down of AChE has been characterized, and the reaction progresses at a very fast rate. 

Cross-linking contributes to tissue strength and limits the need for fiber replacement, but it also inhibits repair following a mechanical injury or infection (Sect. 8.1.3.). Lysyl oxidase catalysis is self-limiting to avoid excessive cross-linking. The oxidation rate of lysine amine residues is limited to approximately 100 catalytic turnovers per enzyme molecule because ammonia and other reaction by-products inactivate it irreversibly. 

The inhibitors of COX enzymes are called nonsteroidal antiinflammatory drugs (NSAIDs) that are prescribed to relieve pain and fever. They stop prostaglandin and thromboxane production. Acetylsalicylic acid (aspirin) was used for this for many years and it was eventually discovered to acetylate a serine residue involved in the dioxygenase action of cyclooxygenases. A second class of NSAIDs, typified by ibuprofen (commonly called Advil or Motrin), inhibits catalysis by attaching irreversibly to cyclooxygenases. Aspirin and ibuprofen inhibit all prostaglandin and thromboxane synthesis. 

Further characterization of the chemical outcome of the tritium label revealed that the tritium was only found in the reduced product dihydrofinasteride and not in finasteride. This suggested that finasteride binding was irreversible and all bound finasteride went through catalysis. The possibility that the product dihydrofi-nasteride was the actual inhibitor was ruled out when it was determined to be a simple, irreversible inhibitor of the enzyme with a A) = 1 nmol H. A more vexing problem for the researchers was that while the overall release of tritium from the H-fmasteride-enzyme complex was >98%, only 30 5% could be recovered as H-dihydrofmasteride. This, combined with the inhibition kinetics of dihydrofmasteride, suggested that the potent inhibitor compound had not yet been isolated. 

Multiple classes of compounds are now known that undergo P450-catalyzed activation to reactive intermediates that irreversibly or quasi-irreversibly inactivate the enzyme responsible for their activation. This irreversible inactivation by a catalytically generated species is superimposed on the reversible inhibition associated with competitive binding of the parent agent to the ferric enzyme. Mechanism-based - (catalysis-dependent) inactivators can be highly enzyme-specific because... 

A significant number of different classes of compounds are known to contain functional groups that have been shown to predispose the molecule to metabolism by particular cytochrome P450 isozymes to form reactive intermediates that can either quasi-irreversibly or irreversibly inactivate the enzyme responsible for their formation. This irreversible inactivation by the reactive species generated catalytically is routinely superimposed on reversible inhibition of the P450 due to competitive binding of the parent compound to the P450 active site. Compounds that inactivate enzymes in this fashion either irreversibly or quasi-irreversibly are considered to be mechanism-based (catalysis-dependent, suicide, or time-dependent) inactivators [132, 133]. Key to this... 

---